• Home >
  • GIL-100 Sales and Investment Attractiveness Index for Healthcare

GIL-100 Sales and Investment Attractiveness Index for Healthcare

Country Attractiveness for Healthcare

25-Jan-2013  /  Research Code: 9A6B-00-02-00-00  /  SKU: LS00252-GL-MR_17683  /  
Region: Global

Regular Price: USD 1,500.00

Special Price USD 1,275.00

15% OFF

* Required Fields

Regular Price: USD 1,500.00

Special Price USD 1,275.00

PAY BY INVOICE

Be the first to review this product

Where should one invest or sell in the aftermath of the financial crisis of 2008 and the on-going European debt crisis? While rich countries have shown very slow growth rates, emerging markets have shown much greater resilience. To increase profitability, you can either find new markets to increase sales, or seek opportunities to invest. Emerging markets will help you do both. The GIL-100 HC Sales and Attractiveness Indices is a generalized model and can be specifically engineered for client growth objectives.

Table of Contents

GIL-100 Sales and Investment Attractiveness Index for HealthcareGIL-100 Sales and Investment Attractiveness IndexGIL-100 HC Index- Methodology and Case Studies




Related Research

US Medical Marijuana Market, Forecast to 2022

Release Date : 18-Jul-18

Region : Global

Why Now is The Time for Interoperable Healthcare Solutions?

Release Date : 05-Jul-18

Region : Global

Growth Insights for European Infectious Disease Point-of-Care Testing (POCT) Market, Forecast to 2022

Release Date : 25-Jun-18

Region : Europe

Global Pharma Clinical Trial Patient Recruitment & Monitoring IT Solutions, Forecast to 2020

Release Date : 17-May-18

Region : North America

Global Laboratory Products Purchasing Trends, 2017–2018

Release Date : 15-Feb-18

Region : Global

Growth Insights on the US Therapeutic Apheresis Market, Forecast to 2021

Release Date : 07-Nov-17

Region : North America

Growth and Investment Opportunities in Nepal Healthcare Market, 2017

Release Date : 06-Nov-17

Region : South Asia, Middle East & North Africa

Growth Insights on the Global CRISPR/Cas9 Tools Market, 2017

Release Date : 31-Oct-17

Region : North America

Global Digital Pathology Market, 2017 Companies-To-Action

Release Date : 31-Oct-17

Region : Global

Growth Opportunities in the Western European Oncology Diagnostics Market, Forecast to 2021

Release Date : 30-Jun-17

Region : Europe

Why Frost & Sullivan

Vision & Strategy

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Brand & Demand

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Technology & IP

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

Global Prespective

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.